Cash is not a problem going forward. Given the lift in spending on advertising and marketing planned for this quarter we can assume Matt has got the unit economics right. If he can ramp sales, then given the amount of effectively free physical capital RAN has to expand production, we should be off to the races.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
RAN
range international limited
Add to My Watchlist
0.00%
!
0.2¢

Cash is not a problem going forward. Given the lift in spending...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.878M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 2070004 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 4938403 | 0.002 |
23 | 50444769 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 2070004 | 6 |
0.004 | 1155263 | 3 |
0.005 | 2454695 | 3 |
0.006 | 2185526 | 2 |
0.007 | 244444 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
RAN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online